PFE
Pfizer Inc.
Latest News for PFE
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has filed a new Phase 1 study, titled “A PHASE 1, OPEN-LAB......
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is advancing a new kidney cancer trial titled “AN INTERVEN......
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has filed a new Phase 1 study, titled “A PHASE 1, OPEN-LAB......
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is advancing a new kidney cancer trial titled “AN INTERVEN......
In a report released today, Trung Huynh from RBC Capital maintained a Sell rating on Pfizer, with a price target of $25.00. Huynh covers the Health......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Upstream Bio, Inc. (UPB) and Pfizer (PFE). Upstrea......
Pfizer ( ($PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer is under intense market scrutin......
In a report released yesterday, Hans Engel from Erste Group maintained a Hold rating on Pfizer. The company’s shares closed yesterday at $28.32. Ac......
Wells Fargo analyst Mohit Bansal maintained a Hold rating on Pfizer today and set a price target of $28.00. According to TipRanks, Bansal is a 5-st......
Pfizer ( ($PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer is back on traders’ radar as Wall ...
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 20 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PFE | $27.47 | 0% | 33.77M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |